PHA
-
DATABASE (66)
-
ARTICLES (2)
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
Entrepreneur First is a global entrepreneur incubator program and early-startup investor. The incubator is an intensive six-month program for founders and aspiring entrepreneurs to help them develop ideas that can go into building their own companies. The program is held in six cities around the world: Bangalore; Berlin, London, Paris, Singapore and Toronto (Canada).Participants do not need to have a startup or a specific business idea to participate, and those who have established their own companies can seek partners or co-founders at the program. Roughly 40-50% of the cohort reach the “Launch” phase, where the participants have established their own companies and received investments from Entrepreneur First and potentially other VCs. Entrepreneur First can invest in a startup built by program participants in exchange for 10% equity. The exact amount invested varies: £80,000 for the European programs; S$75,000 for the Singapore and Bangalore programs; and C$100,000 for the Canada program.
Entrepreneur First is a global entrepreneur incubator program and early-startup investor. The incubator is an intensive six-month program for founders and aspiring entrepreneurs to help them develop ideas that can go into building their own companies. The program is held in six cities around the world: Bangalore; Berlin, London, Paris, Singapore and Toronto (Canada).Participants do not need to have a startup or a specific business idea to participate, and those who have established their own companies can seek partners or co-founders at the program. Roughly 40-50% of the cohort reach the “Launch” phase, where the participants have established their own companies and received investments from Entrepreneur First and potentially other VCs. Entrepreneur First can invest in a startup built by program participants in exchange for 10% equity. The exact amount invested varies: £80,000 for the European programs; S$75,000 for the Singapore and Bangalore programs; and C$100,000 for the Canada program.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
US-French private equity company L Catterton is based in Greenwich, USA, with 17 offices around the world and over $28bn of equity capital. It mostly invests in the consumer industry as well as real estate and technology startups.Founded in 1989 and currently led by co-CEOs Michael Chu and Scott Dahnke, in 2016, L Catterton partnered with the LVMH Group and Groupe Arnault combining Catterton's operations with LVMH and Groupe Arnault's real estate and private equity operations across Europe Asia, and North America. The partnership formed the largest global consumer-focused private equity firm yet the 31st largest private equity firm in the world. L Catterton holds majority stakes in companies like Birkenstock, Crystal Jade, Bliss, John Hardy amongst others; it also invests in technology startups in their growth and hyper-growth phases. Most notable investments include Aleph Farms, ClassPass, and more recently the plant-based products manufacturer NotCo. Its latest growth fund, L Catterton Growth IV, targets an investment range of $10m–$75m in North America and Europe.
US-French private equity company L Catterton is based in Greenwich, USA, with 17 offices around the world and over $28bn of equity capital. It mostly invests in the consumer industry as well as real estate and technology startups.Founded in 1989 and currently led by co-CEOs Michael Chu and Scott Dahnke, in 2016, L Catterton partnered with the LVMH Group and Groupe Arnault combining Catterton's operations with LVMH and Groupe Arnault's real estate and private equity operations across Europe Asia, and North America. The partnership formed the largest global consumer-focused private equity firm yet the 31st largest private equity firm in the world. L Catterton holds majority stakes in companies like Birkenstock, Crystal Jade, Bliss, John Hardy amongst others; it also invests in technology startups in their growth and hyper-growth phases. Most notable investments include Aleph Farms, ClassPass, and more recently the plant-based products manufacturer NotCo. Its latest growth fund, L Catterton Growth IV, targets an investment range of $10m–$75m in North America and Europe.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Bluepha to boost PHA bioplastics production with $30m fresh funding
The Beijing-based startup aims to produce 10,000 tons of PHA bioplastic a year and build a SynBio community through its STEM education spinoff, Bluepha Lab
VEnvirotech: Organic waste converted at source into biodegradable raw bioplastic
The Spanish startup presents an innovative circular business model to stand out in the ever-growing bioplastics sector with its on-site smart-waste container and garbage-consuming bacteria
Sorry, we couldn’t find any matches for “PHA”.
1
POPULAR DATABASE
